Cost-effectiveness of sequential treatment with abaloparatide vs. teriparatide for the prevention of osteoporotic fractures in postmenopausal women at increased risk of fracture.

Reference : Cost-effectiveness of sequential treatment with abaloparatide vs. teriparatide for th...


	Document type :	Scientific congresses and symposiums : Paper published in a journal
	Discipline(s) :	Human health sciences : General & internal medicine
	To cite this reference:	http://hdl.handle.net/2268/223191

Title :	Cost-effectiveness of sequential treatment with abaloparatide vs. teriparatide for the prevention of osteoporotic fractures in postmenopausal women at increased risk of fracture.
Language :	English
Author, co-author :	Hiligsmann, M. []
	Williams, S.A. []
	Fitzpatrick, L.A. []
	Silverman, S. []
	Weiss, R. []
	Reginster, Jean-Yves [Université de Liège - ULiège > Département des sciences de la santé publique > Santé publique, Epidémiologie et Economie de la santé >]
Publication date :	Apr-2018
Journal title :	Osteoporosis International
Publisher :	Springer
Volume :	29 S1
Pages :	302
Peer reviewed :	Yes (verified by ORBi)
On invitation :	No
Audience :	International
ISSN :	0937-941X
e-ISSN :	1433-2965
Country :	Germany
Event name :	World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases
Event date :	du 19 au 22 avril 2018
Event organizer :	WCO-IOF-ESCEO
Event place (city) :	Cracovie
Event country :	Pologne
Permalink :	http://hdl.handle.net/2268/223191

File(s) associated to this reference

Fulltext file(s):

	File	Commentary	Version	Size	Access
Restricted access	Cost-effectiveness of sequential treatment with abaloparatide vs. teriparatide for the prevention of osteoporotic fractures in postmenopausal women at increased risk of fracture..pdf		Publisher postprint	635.05 kB	Request copy

All documents in ORBi are protected by a user license.